<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04591860</url>
  </required_header>
  <id_info>
    <org_study_id>Phasix™ST - Austria</org_study_id>
    <nct_id>NCT04591860</nct_id>
  </id_info>
  <brief_title>A Prospective Randomised Multi - Center Trial on the Repair of Large Hiatal Hernias: Absorbable Mesh vs. Pledgeted Sutures vs. Sutures Only</brief_title>
  <official_title>A Prospective Randomised Multi - Center Trial on the Repair of Large Hiatal Hernias With Sutures Versus Pledgeted Sutures Versus Absorbable Mesh</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Paracelsus Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medical University Innsbruck</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Krankenhaus Barmherzige Schwestern Linz</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Elisabethinen Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Paracelsus Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A prospective randomised multi - center trial on the repair of large hiatal hernias with&#xD;
      sutures versus pledgeted sutures versus absorbable mesh&#xD;
&#xD;
      The primary objective of the present trial is to compare the hiatal hernia recurrence rate&#xD;
      between three different methods of cruroplasty in large hiatal hernias: hiatal closure with&#xD;
      sutures versus pledgeted sutures versus absorbable mesh (Phasix™ST mesh).&#xD;
&#xD;
      The duration of the study is not limited and depends on the number of cases planned. After&#xD;
      enrollment in the study, patients will be followed - up with standardized questionnaires and&#xD;
      gastroscopy at 6 months, 1 year, 3 years and 5 years after surgery.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 1, 2022</start_date>
  <completion_date type="Anticipated">May 1, 2027</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2027</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>The primary objective of the present trial is to compare the hiatal hernia recurrence rate between three different methods of cruroplasty in large hiatal hernias: hiatal closure with sutures versus pledgeted sutures versus absorbable mesh (Phasix™ST mesh).&#xD;
The study includes patients who are scheduled to undergo laparoscopic or robot-assisted surgery for a large symptomatic hiatal hernia. A large hiatal hernia is defined as &gt; 5cm in manometry or gastroscopy or at least 1/3 of the stomach lying intrathoracically. The primary study endpoint is defined as the hernia recurrence rate, objectively assessed by gastroscopy. After inclusion in the study, patients will be followed up 6 months, 1 year, 3 years and 5 years after the operation using standardized questionnaires and gastroscopy.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hiatal hernia recurrence rate</measure>
    <time_frame>6 months, 1 year, 3 years and 5 years after surgery</time_frame>
    <description>Hiatal hernia recurrence rate documented by gastroscopy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of Life evaluated by questionnaire</measure>
    <time_frame>Prior to surgery; 6 months, 1 year, 3 years and 5 years after surgery</time_frame>
    <description>Quality of Life measured by Gastrointestinal Quality of Life Index (GIQLI)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Symptoms related to Gastroesophageal Reflux Disease (GERD)</measure>
    <time_frame>Prior to surgery; 6 months, 1 year, 3 years and 5 years after surgery</time_frame>
    <description>Typical and atypical GERD symptoms assessed by the Symptom Check List (SCL) in units of a scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Primary extraesophageal GERD symptoms related to Gastroesophageal Reflux Disease (GERD)</measure>
    <time_frame>Prior to surgery; 6 months, 1 year, 3 years and 5 years after surgery</time_frame>
    <description>Primary atypical GERD symptoms assessed by the Reflux Symptom Index (RSI - Score) in units of a scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative complications</measure>
    <time_frame>6 months, 1 year, 3 years and 5 years after surgery</time_frame>
    <description>Short - term and long - term complications after treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>up to 90 days</time_frame>
    <description>Length of hospital stay and mortality rates</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Predictive parameters for treatment response or failure I</measure>
    <time_frame>Prior to surgery; 6 months, 1 year, 3 years and 5 years after surgery</time_frame>
    <description>Weight (in kilograms)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Predictive parameters for treatment response or failure II</measure>
    <time_frame>Prior to surgery; 6 months, 1 year, 3 years and 5 years after surgery</time_frame>
    <description>Height (in meters)</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">165</enrollment>
  <condition>Hiatal Hernia</condition>
  <arm_group>
    <arm_group_label>Sutures only</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients with a large hiatal hernia undergo the cruroplasty with sutures only.&#xD;
A large hiatal hernia is defined as &gt; 5cm in manometry or gastroscopy or at least 1/3 of the stomach lying intrathoracically.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Absorbable Mesh</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients with a large hiatal hernia undergo the cruroplasty with mesh implantation.&#xD;
A large hiatal hernia is defined as &gt; 5cm in manometry or gastroscopy or at least 1/3 of the stomach lying intrathoracically.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pledgeted sutures</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients with a large hiatal hernia undergo the cruroplasty with pledgeted sutures.&#xD;
A large hiatal hernia is defined as &gt; 5cm in manometry or gastroscopy or at least 1/3 of the stomach lying intrathoracically.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Laparoscopic or robot-assisted hiatal closure (sutures only vs. absorbable mesh vs. pledgeted sutures) and fundoplication according to Toupet</intervention_name>
    <description>Patients are scheduled to undergo laparoscopic or robot-assisted surgery for a large symptomatic hiatal hernia.The hiatal closure will be done with sutures, pledgeted sutures or absorbable mesh (Phasix™ST mesh). After cruroplasty a fundoplication according to Toupet will be done additionally.</description>
    <arm_group_label>Absorbable Mesh</arm_group_label>
    <arm_group_label>Pledgeted sutures</arm_group_label>
    <arm_group_label>Sutures only</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with a large hiatal hernia - admitted for surgery (laparoscopic /&#xD;
             robot-assisted)&#xD;
&#xD;
          -  Written informed consent&#xD;
&#xD;
          -  ≥ 18 years of age&#xD;
&#xD;
          -  Hiatal hernia documented by barium x-ray and/or gastroscopy and/or manometry by one or&#xD;
             more of the following criteria:&#xD;
&#xD;
               -  &gt; 5cm hiatal hernia&#xD;
&#xD;
               -  1/3 of the stomach in the thorax&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Lack of patient consent for study participation&#xD;
&#xD;
          -  Lack of consent to study due to linguistic or mental incomprehension&#xD;
&#xD;
          -  Patients in poor general condition (lack of anesthesia ability)&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Prior surgery on the stomach or gastroesophageal junction&#xD;
&#xD;
          -  Simultaneous surgery because of another illness&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Michael Weitzendorfer, MD, PhD</last_name>
    <phone>+435725551078</phone>
    <email>m.weitzendorfer@salk.at</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Oliver O Koch, MD, FEBS</last_name>
    <phone>+435725551091</phone>
    <email>o.koch@salk.at</email>
  </overall_contact_backup>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 17, 2020</study_first_submitted>
  <study_first_submitted_qc>October 12, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 19, 2020</study_first_posted>
  <last_update_submitted>September 15, 2021</last_update_submitted>
  <last_update_submitted_qc>September 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Paracelsus Medical University</investigator_affiliation>
    <investigator_full_name>Michael Weitzendorfer, MD</investigator_full_name>
    <investigator_title>Dr. Michael Weitzendorfer, PhD</investigator_title>
  </responsible_party>
  <keyword>hiatal hernia</keyword>
  <keyword>pledgets</keyword>
  <keyword>mesh</keyword>
  <keyword>hernia recurrence</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hernia</mesh_term>
    <mesh_term>Hernia, Hiatal</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

